Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-08 Sale |
2021-11-08 6:22 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $39.82 | $1,990,768 | 687,160 (Direct) |
View |
| 2021-11-05 Sale |
2021-11-05 5:59 pm |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
32,000 | $40.38 | $1,292,113 | 181,983 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-04 7:37 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $40.09 | $2,004,390 | 737,160 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-01 7:32 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
29,450 | $39.93 | $1,175,968 | 156,846 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-07 5:46 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $42.38 | $2,118,846 | 787,160 (Direct) |
View |
| 2021-08-25 Sale |
2021-08-25 5:54 pm |
HALOZYME THERAPEUTICS INC. | HALO | BIZZARI JEAN-PIERRE Director |
35,000 | $41.01 | $1,435,455 | 52,544 (Direct) |
View |
| 2021-08-10 Sale |
2021-08-10 7:01 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $41.11 | $2,055,576 | 837,160 (Direct) |
View |
| 2021-07-06 Sale |
2021-07-06 6:09 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $45.97 | $2,298,650 | 887,160 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-06 5:19 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
40,315 | $45.7 | $1,842,315 | 148,796 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-07 6:53 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $39.66 | $1,982,950 | 937,160 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-11 6:22 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $43.02 | $2,151,099 | 987,160 (Direct) |
View |
| 2021-04-14 Sale |
2021-04-14 4:19 pm |
HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director |
5,000 | $45 | $225,000 | 179,833 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-05 7:51 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $42.55 | $2,127,250 | 1,037,160 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-01 7:44 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
28,689 | $42.56 | $1,221,037 | 134,111 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-05 Option Award |
2022-05-06 8:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
6,206 | $0 | 59,045 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 8:05 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director |
6,206 | $0 | 32,438 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 8:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Connaughton Bernadette Director |
6,206 | $0 | 38,219 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 8:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | BIZZARI JEAN-PIERRE Director |
6,206 | $0 | 58,750 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-17 6:04 pm |
2023-02-16 2032-02-16 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
99,225 | $0 | 282,520 (Direct) |
View |
| 2022-02-15 Exercise |
2022-02-17 6:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
3,386 | $0 | 282,520 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-17 6:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
1,170 | $34.43 | 282,520 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-17 6:03 pm |
2023-02-16 2032-02-16 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
82,688 | $0 | 95,495 (Direct) |
View |
| 2022-02-15 Exercise |
2022-02-17 6:03 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
1,255 | $0 | 95,495 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-17 6:03 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
433 | $34.43 | 95,495 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-17 6:02 pm |
2023-02-16 2032-02-16 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
341,083 | $0 | 967,536 (Direct) |
View |
| 2022-02-15 Exercise |
2022-02-17 6:02 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
13,092 | $0 | 967,536 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-17 6:02 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
6,892 | $34.43 | 967,536 (Direct) |
View |
| 2022-02-12 Tax Withholding |
2022-02-14 7:29 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
2,725 | $34.2 | 195,070 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-14 7:29 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
1,995 | $33.64 | 195,070 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 7:29 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
21,787 | $0 | 195,070 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 7:29 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
2,992 | $34.94 | 195,070 (Direct) |
View |
| 2022-02-12 Tax Withholding |
2022-02-14 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
506 | $34.2 | 14,617 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-14 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
427 | $33.64 | 14,617 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
5,148 | $0 | 14,617 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
1,025 | $34.94 | 14,617 (Direct) |
View |
| 2022-02-12 Tax Withholding |
2022-02-14 7:27 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
17,266 | $34.2 | 676,333 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-14 7:27 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
15,125 | $33.64 | 676,333 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 7:27 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
92,806 | $0 | 676,333 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 7:27 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
16,598 | $34.94 | 676,333 (Direct) |
View |
Ownership |
2022-02-11 4:21 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
0 | $0 | 123,456 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:13 pm |
2023-01-03 2032-01-03 |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, General Counsel |
113,586 | $0 | 113,586 (Direct) |
View |
| 2021-11-08 Exercise |
2021-11-08 6:22 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 687,160 (Direct) |
View |
| 2021-10-12 Exercise |
2021-10-12 7:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
8,050 | $13.1 | 156,846 (Direct) |
View |
| 2021-10-12 Exercise |
2021-10-12 7:06 pm |
N/A 2024-02-06 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
8,050 | $0 | 156,846 (Direct) |
View |
| 2021-10-04 Exercise |
2021-10-04 7:37 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 737,160 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-01 7:32 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
29,450 | $13.1 | 156,846 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-01 7:32 pm |
N/A 2024-02-06 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
29,450 | $0 | 156,846 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-07 5:46 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 787,160 (Direct) |
View |
| 2021-09-04 Tax Withholding |
2021-09-07 5:42 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
3,412 | $42.22 | 26,932 (Direct) |
View |
| 2021-09-04 Exercise |
2021-09-07 5:42 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
6,883 | $0 | 26,932 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-10 7:01 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 837,160 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-15 7:36 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
14,685 | $6.55 | 148,796 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-15 7:36 pm |
N/A 2023-02-04 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
14,685 | $0 | 148,796 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-06 6:09 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 887,160 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-06 5:19 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
40,315 | $6.55 | 148,796 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-06 5:19 pm |
N/A 2023-02-04 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
40,315 | $0 | 148,796 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-07 6:53 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 937,160 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-11 6:22 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 987,160 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-06 8:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
5,230 | $0 | 128,983 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-06 8:03 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
5,230 | $0 | 213,983 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-06 8:02 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
5,230 | $0 | 52,839 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-06 8:01 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director |
5,230 | $0 | 26,232 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-06 8:01 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Connaughton Bernadette Director |
5,230 | $0 | 32,013 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-06 8:00 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | BIZZARI JEAN-PIERRE Director |
5,230 | $0 | 87,544 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-03 8:27 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
11,311 | $11.29 | 134,111 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-03 8:27 pm |
N/A 2022-02-02 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
11,311 | $0 | 134,111 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-05 7:51 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 1,037,160 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-01 7:44 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
28,689 | $11.29 | 134,111 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-01 7:44 pm |
N/A 2022-02-12 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
28,689 | $0 | 134,111 (Direct) |
View |
| 2021-04-01 Tax Withholding |
2021-04-01 7:43 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
4,059 | $42.43 | 44,618 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-01 7:43 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
10,196 | $0 | 44,618 (Direct) |
View |
| 2021-03-02 Tax Withholding |
2021-03-02 7:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
4,285 | $45.01 | 44,377 (Direct) |
View |
| 2021-03-02 Exercise |
2021-03-02 7:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
12,166 | $0 | 44,377 (Direct) |
View |